Ticker ATRA – Atara Biotherapeutics Inc – sales, description, marketcap – Tickerday.com

ATRA

Atara Biotherapeutics Inc

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 985.32M; Volume: 101.43K; AvgVol 3m: 908.54K; Beta: –;

Cost estimate:

P/E: –; EPS: -5.01; EPS growth quarter/prev quarter: 28.80%;

EPS growth this year: -7.70%; EPS growth past 5 years: -0.20%;

EPS ttm: -5.01;

P/S: ; P/B: 2.49; P/Cashflow: 03.02; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -84.00%; ROE – return on equity: -97.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.10%; Insider Transactions:-3.60%;

Institutional Ownership: ; Institutional Transactions: 24.43%;

Data update: 07/10/2020.